We have previously demonstrated the role of hepatitis C virus (HCV) core protein in the transcriptional regulation of cellular and unrelated viral promoters. Furthermore, the core protein in cooperation with H-ras oncogene transforms primary rat embryo fibroblast cells to the tumorigenic phenotype. In the present study, the functional role of HCV core protein was investigated to determine its potential to inhibit the onset of apoptotic cell death. Expression of HCV core protein inhibited cisplatin mediated apoptosis in human cervical epithelial cells, and apoptosis induced by the overexpression of c-myc in Chinese hamster ovarian cells. Results from these studies suggest that the core protein may have a biological implication in the pathogenesis of HCV infection. ᭧
INTRODUCTION
by the blocking of E2 binding to cells, whereas in infection such antibodies are at low levels or are absent (Rose Hepatocellular carcinoma (HCC) is among the most et al., 1996) . The extent to which cellular immunity opercommon malignant tumors worldwide. While it has long ates as a mechanism of protective immunity against HCV been recognized that the development of HCC is strongly is still undefined (Erickson et al., 1993) . associated with chronic hepatitis B viral (HBV) infection, HCV contains a single-stranded positive sense RNA it has only been recently noted that a similar association genome of approximately 10 kb in length which encodes may be evident with hepatitis C virus (HCV) infection (Di a polypeptide precursor of Ç3000 amino acids. The pre-Bisceglie, 1995) . This recognition has resulted from the cursor polypeptide is cleaved into its functional units by development of sensitive and specific assays to detect both viral and host proteases, producing at least nine HCV infection (Choo et al., 1989; Kuo et al., 1989) . Comdistinct polypeptides from these cleavage events. The pelling data indicate that as many as 90% of infected putative structural proteins, core, E1, and E2 (p7), are individuals do not resolve their infection and become located in the amino-terminal quarter of the viral precurlifelong chronic carriers of HCV, causing a significant sor and are proteolyticaly cleaved by host signalases number of deaths per year (The Jordan Report, 1995) .
localized to the endoplasmic reticulum; and the nonstruc-Individuals may show no overt symptoms of hepatitis, but tural proteins are processed by HCV-specific proteinases some infected persons progress to cirrhosis and HCC. (Hijikata et al., 1991; Grakoui et al., 1993a,b; Selby et al., Understanding the viral basis for HCV persistence in the 1993). The core protein is relatively conserved among all face of a polyclonal humoral and cellular immune reidentified HCV isolates (Bukh et al., 1994) . The carboxylsponse is a major challenge (Cerny and Chisari, 1994) .
terminus of the core protein has been established to be This must be met in order to understand the immunobiolat amino acid position 191 (Hijikata et al., 1991) . HCV ogy and pathogenesis of, and to permit the rational dehas a replicative cycle that most likely takes place in the sign of effective strategies for the prevention and treatcytoplasm. The core protein may be the fundamental unit ment of, this serious infection. The majority of HCV-infor encapsidation of genomic RNA to help in virus morfected humans show evidence of an antibody response phogenesis. However, nuclear localization of the core to the E1 and E2 glycoproteins (Chien et al., 1993; Ray protein (Shih et al., 1993; Lo et al., 1995 Lo et al., ) raises questions et al., 1994 . However, the generation of isolate-specific concerning its further biological significance. A transneutralizing antibody responses and serotypic variation regulatory function of the core protein on cellular and are probably significant features of HCV infection (Farci viral promoters has previously been observed (Shih et et al., 1994; Purcell, 1994) . Recent studies suggest that al., 1993; Ray et al., 1995) . Furthermore, the core protein vaccination can induce high antibody titers as measured in cooperation with H-ras transforms primary rat embryo fibroblasts to the tumorigenic phenotype , potentially implicating its biological role in the de-hibit this mechanism (White, 1996) . Recent evidence sug-protein in the inhibition of cellular apoptosis. An external causative agent such as UV light or cisplatin, an antican-gests that alterations in cell survival contribute to the pathogenesis of a number of human diseases, including cer agent, have been shown to induce an apoptotic response (Zhu et al., 1995; Fritsche et al., 1993) in a manner viral oncogenesis (Thompson, 1995) . In the present study, we investigated the functional role of HCV core which facilitates the study of this phenomenon and its regulation. Initial analyses to determine the extent of HCV protein in the abrogation of apoptotic cell death mediated by a number of established stimuli. Our results demon-core-mediated regulation of apoptosis were carried out utilizing core-expressing HeLa cells as the experimental strate that HCV core protein suppresses cisplatin-and c-myc-mediated apoptosis and may have a role in the and vector DNA transfected cells as the positive control following treatment with cisplatin or by UV irradiation. establishment of persistent infection.
Briefly, Ç2 1 10 5 cells were plated onto 35-mm dishes MATERIALS AND METHODS 20 hr prior to treatment with cisplatin. After the cells were exposed to cisplatin for a predetermined length of time, Cell culture adherent and nonadherent cells were collected for analy-Human cervical carcinoma cells (HeLa) were obtained ses of apoptotic cell death (Ray, 1995) . from the American Type Culture Collection. A primary
The aberrant overexpression of c-myc in CHO cells baby rat kidney cell line cotransformed with a ts mutant results in apoptotic cell death (Bissonnette et al., 1992) . of p53 (p53val 135 ) and adenovirus E1A (BRK/p53val 135 -To determine whether the core protein could prevent E1A) was kindly provided by G. Chinnadurai (Institute for apoptosis induced by the overexpression of c-myc, stable Molecular Virology, Saint Louis University, St. Louis, MO).
transfectants of 5A100 cells expressing the core protein Cells were grown in Dulbecco's modified Eagle's medium were utilized. The effect of HCV core gene on c-myc supplemented with 10% heat-inactivated fetal calf serum protein expression in transfected cells was also deter-(FCS). Chinese hamster ovary (CHO) cells overexmined by Western blot analysis using rabbit anti-mouse pressing the mouse c-myc gene under the regulation of c-myc antibody (kindly provided by Douglas Green). The a heat shock promoter (5A100) were kindly provided by control 5A100 cells or cells expressing HCV core protein Douglas Green (La Jolla Institute for Allergy and Immuwere incubated at 43Њ in a water bath for various lengths nology, La Jolla, CA) and were propagated in Iscove's of time, followed by incubation in a CO 2 incubator at 37Њ. modified DMEM supplemented with 10% FCS, 2 mM L-Unless otherwise stated, adherent and nonadherent cells glutamine, and 50 mM methotrexate.
were collected after 24 hr to analyze the extent to which apoptotic cell death has progressed.
Plasmid construction and generation of HCV core
To investigate the involvement of p53, the BRK/ expressing cell lines p53val 135 -E1A was used. This cell line undergoes rapid Amplification and cloning of HCV-1 core genomic seand total apoptosis when the p53 protein assumes the quences have been previously described (Lagging et al., wild-type conformation at 32.5Њ. Inhibition of p53-medi-1995). Briefly, the plasmid Blue4/C5p-1 (kindly provided ated apoptosis by HCV core protein was determined folby M. Houghton, Chiron Corp., Emeryville, CA) was used lowing a similar methodology as described earlier (Suas a template in polymerase chain reaction (PCR) to ambramanian et al., 1995) . BRK/p53val 135 -E1A cells stably plify the genomic region encoding the core protein transfected with the MuLV/core plasmid DNA or vector (amino acids 1-191) of HCV. The amplified DNA was DNA were tested for cell survival at 32.5Њ. Trypan bluecloned into the pBabe/puro vector (Ray, 1995) under the excluding cells were counted to measure the starting control of murine leukemia virus long terminal repeat viable cell number, while the rest of the dishes were (MuLV/core) for expression of HCV core protein in cells. transferred to 32.5Њ. Similar cell viability counts were Subconfluent HeLa, 5A100 (Bissonnette et al., 1992) , and taken at different time points. BRK/p53val 135 -E1A (Subramanian et al., 1995) cells were transfected with MuLV/core (experimental) or vector DNA (control) using the lipofectamine reagent (Gibco BRL, Gaith-Analyses for apoptotic cell death ersburg, MD). Puromycin-resistant stable transfectants were selected and pooled. Cells were tested to confirm the The apoptotic response was monitored from cell viabilintegration of HCV core gene and protein expression as ity by trypan blue exclusion and experiments were done recently described . The cell lines expressin triplicate. DNA fragmentation was analyzed by agarose ing HCV core protein were used to study its potential to gel electrophoresis following a procedure previously deinhibit the apoptotic response.
scribed (Ray, 1995) . A terminal deoxynucleotidyltransferase (TdT)-mediated dUTP nick end labeling (TUNEL) Induction and abrogation of apoptotic cell death assay (Boehringer Manheim, IN) was also used for in situ detection of DNA degradation following the supplier's A number of treatments known to induce an apoptotic response were utilized to examine the role of the core procedure.
period, with a complete termination of the culture by Day 3. Endonucleolysis, a key biochemical event of apoptosis, results in the cleavage of nuclear DNA into apoptotic signature oligonucleosome fragments. DNA from vector transfected HeLa cells showed the characteristic ladder formation which was not visible in the HCV core gene transfected cells (figure not shown). TUNEL assay was also used for in situ detection of DNA degradation after 24 hr to monitor cellular apoptosis. Both vector DNA and core gene transfected HeLa cells were visualized, and the characteristic fluorescence is shown (Fig. 3) . Vector DNA transfected HeLa cells undergoing apoptotic death retained fluorescein conjugated TdT in their degraded DNA strands, resulting in a bright fluorescence (Fig. 3A) , whereas stable transfectants of cells expressing HCV core protein did not exhibit detectable fluorescence ( Fig. 3B ). Results from this study suggested that HeLa cells constitutively expressing HCV core protein inhibit cisplatin-mediated apoptosis.
HCV core protein does not inhibit apoptosis induced by UV irradiation
HeLa cells constitutively expressing core protein or tutive expression of HCV core protein was unable to confer any significant protection from cell death. Monitor-
RESULTS
ing by trypan blue exclusion revealed no greater than a 5% increase in the number of viable cells expressing Abrogation of cisplatin-mediated apoptosis by HCV core protein compared to vector DNA transfected con-core protein trols. The appearance of oligonuclear fragments from HeLa cells constitutively expressing HCV core as a the vector DNA and HCV core transfected HeLa cells nucleocytoplasmic protein (Figs. 1A and 1B) were used indicated that the core protein conferred little or no proto analyze the inhibition of cisplatin-mediated apoptosis.
tection from UV-mediated apoptosis (figure not shown). Expression of the core protein in HeLa cells did not induce a detectable change in the growth pattern com-Inhibition of c-myc-mediated apoptotis by HCV core pared to the parental cell line. Initially, culture medium protein containing different concentrations (10, 20, 30 or 40 mM) of cisplatin were used to determine a dose-dependent
To determine whether HCV core protein prevents cmyc-mediated apoptosis, 5A100 cells overexpressing an response to the drug-induced cell death ( Fig. 2A) . In vector transfected positive control HeLa cells, significant cell amplified c-myc under the control of a heat shock promoter (Bissonnette et al., 1992) were utilized. Vector death was apparent at cisplatin concentrations approximating 20 mM and above. In contrast, the core expressing transfected 5A100 cells were initially tested at various times (30, 45, 60, or 75 min) for activation of the heat cell line exhibited the ability to inhibit the onset of apoptosis at cisplatin concentrations reaching 30 mM. In shock promoter followed by incubation at 37Њ for approximately 24 hr. Cells heat induced for 60 min appeared to subsequent experiments, cells were treated with 20 mM cisplatin and the number of viable cells after successive offer the best results of c-myc-mediated apoptosis. The 5A100 cell line transfected with HCV core gene showed days of incubation is shown (Fig. 2B ). Significant viability was maintained in HeLa cells constitutively expressing nucleocytoplasmic expression of the core protein (Figs.  1C and 1D) . The difference in intensity of immunofluores-HCV core protein during the 3 days of the observation period. As apparent from the given figure, the contiguous cence between 5A100 and HeLa cells ( Figs. 1A and 1B ) may be due to the level of expression of the core protein culture of vector transfected HeLa cells exhibited a rapid decline in viable cell number throughout the incubation in these two different cell lines. The transfected 5A100 cells did not show a detectable change in the growth characteristic DNA ladder formation exhibited by heatinduced 5A100 cells (Fig. 5) indicates a level of protection characteristics compared to the parental cell line. Subsequently, the stable transfectants and vector transfected conferred by the core protein. 5A100 cells were incubated at 43Њ for 60 min to activate the heat shock promoter and induce the overexpression Test for the inhibitory role of HCV core protein in of c-myc. At 24 hr postinduction, adherent and nonadher-p53-mediated cell death ent cells were collected for a viable cell count and analyses of genomic DNA oligonucleosomal fragmentation.
p53 is a potent inducer of apoptosis, which contributes to its function as a tumor suppressor gene (Lane, 1992; 5A100 cells expressing HCV core protein showed Ç50% higher cell viability than the vector transfected 5A100 Levine, 1993) . p53-induced growth arrest and apoptosis are well-known cellular responses to DNA damaging cells after 24 hr of c-myc induction (Fig. 4) . Since the halflife of c-myc is short, after heat induction its expression at agents, although several lines of evidence suggest that p53-independent apoptotic pathways also exist (Hsu et 5 hr in both HCV core gene transfected and vector DNA transfected cells was tested using rabbit anti-mouse c-al., 1991; Strasser et al., 1994; Symonds et al., 1994) . The onset of apoptosis induced by cisplatin and overex-myc antibody by Western blot analysis and both cell types showed a similar level of protein expression (figure pression of c-myc may occur through the accumulation of the tumor suppressor protein, p53. To test the possibil-not shown). Thus, HCV core protein did not appear to alter c-myc expression in the 5A100 stable transfectants.
ity of p53 involvement, HCV core gene transfected BRK/ p53val 135 -E1A cells were tested for the inhibition of In the presence of HCV core protein, the absence of the ing the Bcl-2 protein, blocking p53 function, inhibiting the activity of interleukin-1b-converting enzyme family members or upregulation of insulin-like growth factor II (Subramanian et al., 1995; Wang et al., 1995; Ueda and Ganem, 1996; Vaux and Strasser, 1996; White, 1996) . The pathology of HCV infection evolves around the development of a chronic, persistent infection with the potential for progression into HCC. The mechanism by which HCV maintains viral persistence and promotes tumor formation in the liver is not at present understood.
Replication of HCV has been reported in a number of mammalian cells including human primary hepatocytes (Ito et al., 1996) . However, efficient long-term virus replication has not been described in any system. In fact, there is no report of successful purification of HCV for biochemical analyses from either cultured cells or tis- surface and specific functions that support viral growth. It is, therefore, difficult to study the biological properties apoptosis. A difference in cell survival was not observed and pathogenicity of HCV. Consequently, in the absence from p53-mediated apoptosis in the presence or absence of unequivocal evidence for a common ancestry, all inforof HCV core gene in BRK/p53val 135 -E1A cells under our mation about the mechanism of HCV replication at the experimental conditions. This result suggested that the molecular level so far has depended on the comparative HCV core protein exerts its antiapoptotic activity upanalysis and expression of its partial or entire genome stream of the p53 pathway or independent of p53 activity.
with those of distantly related flaviviruses or pestiviruses (Suzuki et al., 1995; Zanotto et al., 1996) . The chronicity of HCV infections and the histopathologic findings indi-DISCUSSION cate that the virus is probably not directly cytopathic (or cytolytic) in hepatocytes (Shirai et al., 1994) . In addition Since the HCV core protein modulates cellular promoters at the transcriptional level and transforms primary to the potential role of core protein in the encapsidation of HCV genomic RNA, it may have other biological func-rat embryo fibroblast cells in cooperation with the H-ras oncogene to the tumorigenic phenotype, the ability of tions in an infected cell. Core protein is highly basic this protein to inhibit the onset of apoptotic cell death was considered. The results from this study demonstrate the inhibitory role of the core protein with regard to cisplatin-and c-myc-mediated apoptosis. Both cisplatinand c-myc-mediated apoptotic cell death may occur through the accumulation of the tumor suppressor protein p53 (Lane, 1992; Wagner et al., 1994) . However, the core protein failed to protect apoptotic cell death mediated either by UV irradiation or by p53 under our experimental conditions. Cells exposed to infectious agents initiate death programs as defensive mechanisms. The role of a number of viral proteins in the induction or suppression of apoptosis has been described. An adenovirus E1A-induced apoptotic response is abrogated by E1B, thereby sustaining viral persistence in the host (Rao et al., 1992) . have been suggested. These include mimicking or induc-(isoelectric point 12.05) and could in principle show affin-REFERENCES ity toward nucleic acids and translocate to the nucleus Bissonnette, R. P., Fernando, E., Mahboubi, A., and Green, D. R. (1992). during the mitotic phase, when the nuclear membrane Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature is absent (Ravaggi et al., 1994) . Our results suggest that 359, 552-554. the HCV core protein exerts some functional control over Bukh, J., Purcell, R. H., and Miller, R. H. (1994) . Sequence analysis of the process of cellular apoptosis, although the biological the core gene of 14 hepatitis C virus genotypes. Proc. Natl. Acad.
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